E799 E799 Pill - red capsule/oblong, 18mm
Pill with imprint E799 E799 is Red, Capsule/Oblong and has been identified as Rifampin 300 mg. It is supplied by Sandoz Pharmaceuticals Inc.
Rifampin is used in the treatment of Bartonellosis; Endocarditis; Haemophilus influenzae Prophylaxis; Legionella Pneumonia; Leprosy and belongs to the drug class rifamycin derivatives. Risk cannot be ruled out during pregnancy. Rifampin 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for E799 E799




Rifampin
- Imprint
- E799 E799
- Strength
- 300 mg
- Color
- Red
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Rifamycin derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Pharmaceuticals Inc
- Inactive Ingredients
-
silicon dioxide,
corn starch,
docusate sodium,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
magnesium stearate,
microcrystalline cellulose,
sodium benzoate,
propylene glycol,
ferrosoferric oxide,
magnesium silicate,
shellac,
titanium dioxide,
D&C Yellow No. 10
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00185-0799 | Eon Labs Inc. |
00904-5282 | Major Pharmaceuticals |
51079-0890 (Discontinued) | UDL Laboratories Inc. |
63739-0415 | McKesson Packaging Services |
54569-5770 (Discontinued) | A-S Medication Solutions, LLC (repackager) |
54868-4683 (Discontinued) | Physicians Total Care Inc. (repackager) |
More about rifampin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (22)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: rifamycin derivatives
- Breastfeeding
- En español
Patient resources
- Rifampin drug information
- Rifampin (Intravenous) (Advanced Reading)
- Rifampin (Oral) (Advanced Reading)
- Rifampin Capsules
Other brands
Rifadin, Rifadin IV, Rimactane
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.